E1 ReplicatedModerate confidencePEM not requiredRCTPeer-reviewedMachine draft
Standard · 3 min
Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome.
Wearden, A J, Morriss, R K, Mullis, R et al. · The British journal of psychiatry : the journal of mental science · 1998 · DOI
Quick Summary
This study tested whether graded exercise and/or a antidepressant medication called fluoxetine could help people with ME/CFS. Researchers randomly assigned 136 patients to receive either exercise, medication, both, or neither over 6 months. Exercise showed modest benefits for fatigue and physical function, while the medication only helped with depression symptoms, and many patients found it difficult to stick with the exercise program.
Why It Matters
This is one of the earlier rigorous randomised controlled trials examining recommended first-line treatments (GET and antidepressants) for ME/CFS, providing empirical evidence about their relative efficacy and tolerability. Understanding which treatments produce meaningful functional improvements versus symptom management is critical for clinical decision-making and patient counselling.
Observed Findings
Exercise reduced case-level fatigue compared to appointments-only at 26 weeks (6% vs 18%, P=0.025).
Exercise improved functional work capacity at 12 weeks (P=0.005) and 26 weeks (P=0.03).
Exercise significantly improved health perception at 28 weeks (P=0.012) and fatigue at 28 weeks (P=0.028).
Fluoxetine showed significant benefit for depression at week 12 only (P=0.04), with no sustained effect.
Patients were significantly more likely to drop out of exercise treatment than non-exercise treatment (P=0.05).
Inferred Conclusions
Graded exercise produced measurable improvements in functional work capacity and fatigue perception, suggesting it may have a role in CFS management.
Fluoxetine's antidepressant effects were limited and transient, with no sustained benefit beyond week 12.
The acceptability of GET is questionable, given higher dropout rates in exercise-assigned groups.
Exercise appears more effective than medication alone or no treatment for improving fatigue-related outcomes.
Remaining Questions
Why do patients drop out of graded exercise more frequently, and are they experiencing symptom exacerbation or simply finding the regimen burdensome?
What This Study Does Not Prove
This study does not prove that GET is universally beneficial or safe for all ME/CFS patients, as it does not stratify by baseline severity or post-exertional malaise severity, and high dropout rates suggest the intervention may be poorly tolerated by some. It does not establish that fluoxetine is ineffective overall, only that its benefits were limited to depression at one timepoint. The study does not address whether patients experienced harms or worsening symptoms during or after the intervention.
Tags
Symptom:Cognitive DysfunctionFatigue
Method Flag:PEM Not DefinedWeak Case DefinitionMixed Cohort
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →